Full text
PDF

Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aronson J. K. Digitalis intoxication. Clin Sci (Lond) 1983 Mar;64(3):253–258. doi: 10.1042/cs0640253. [DOI] [PubMed] [Google Scholar]
- Cumberbatch M., Zareian K., Davidson C., Morgan D. B., Swaminathan R. The early and late effects of digoxin treatment on the sodium transport, sodium content and Na+K+- ATPase or erythrocytes. Br J Clin Pharmacol. 1981 Jun;11(6):565–570. doi: 10.1111/j.1365-2125.1981.tb01172.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dobbs S. M., Kenyon W. I., Dobbs R. J. Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients. Br Med J. 1977 Mar 19;1(6063):749–752. doi: 10.1136/bmj.1.6063.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ESTES J. W., WHITE P. D. WILLIAM WITHERING AND THE PURPLE FOXGLOVE. Sci Am. 1965 Jun;212:110–119. doi: 10.1038/scientificamerican0665-110. [DOI] [PubMed] [Google Scholar]
- Fleg J. L., Gottlieb S. H., Lakatta E. G. Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm. Am J Med. 1982 Aug;73(2):244–250. doi: 10.1016/0002-9343(82)90186-3. [DOI] [PubMed] [Google Scholar]
- Ford A. R., Aronson J. K., Grahame-Smith D. G., Carver J. G. The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy. Br J Clin Pharmacol. 1979 Aug;8(2):135–142. doi: 10.1111/j.1365-2125.1979.tb05811.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- George C. F. Digitalis intoxication: a new approach to an old problem. Br Med J (Clin Res Ed) 1983 May 14;286(6377):1533–1534. doi: 10.1136/bmj.286.6377.1533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee D. C., Johnson R. A., Bingham J. B., Leahy M., Dinsmore R. E., Goroll A. H., Newell J. B., Strauss H. W., Haber E. Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med. 1982 Mar 25;306(12):699–705. doi: 10.1056/NEJM198203253061202. [DOI] [PubMed] [Google Scholar]
- Mulrow C. D., Feussner J. R., Velez R. Reevaluation of digitalis efficacy. New light on an old leaf. Ann Intern Med. 1984 Jul;101(1):113–117. doi: 10.7326/0003-4819-101-1-113. [DOI] [PubMed] [Google Scholar]
- Noble D. Mechanism of action of therapeutic levels of cardiac glycosides. Cardiovasc Res. 1980 Sep;14(9):495–514. doi: 10.1093/cvr/14.9.495. [DOI] [PubMed] [Google Scholar]
- Sonnenblick M., Abraham A. S., Meshulam Z., Eylath U. Correlation between manifestations of digoxin toxicity and serum digoxin, calcium, potassium, and magnesium concentrations and arterial pH. Br Med J (Clin Res Ed) 1983 Apr 2;286(6371):1089–1091. doi: 10.1136/bmj.286.6371.1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taggart A. J., Johnston G. D., McDevitt D. G. Digoxin withdrawal after cardiac failure in patients with sinus rhythm. J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):229–234. doi: 10.1097/00005344-198303000-00011. [DOI] [PubMed] [Google Scholar]

